4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000114
Options or other derivatives
- Director acquired 52,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Owen Director | 2023-11-16 | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1700515278.xml…